For research use only. Not for therapeutic Use.
Sepin-1 is a potent separase inhibitor with an IC50 value of 14.8 µM. Sepin-1 inhibits cell proliferation, migration and wound healing. Sepin-1 decreases the expression of FoxM1 protein and mRNA level. Sepin-1 shows anti-tumor activity[1][2].
Sepin-1 (0, 20, 40 µM; 24 h) inhibits cell migration and wound healing, and causes DNA damage[1].
Sepin-1 (0, 10, 20, 40 µM; 24 h) decreases the expression of FoxM1 protein and mRNA level in a dose-dependent manner[1].
Sepin-1 (0, 10, 20, 40 µM; 24 h) inhibits the expression of Plk1, Cdk1, pericentrin, Aurora, and Lamin B1 protein levels[1].
Sepin-1 (10 mg/kg; i.v.; daily for 5 days a week for 3 weeks) shows anti-tumor activity in mice[2].
Catalog Number | I036223 |
CAS Number | 163126-81-6 |
Synonyms | 2,2-dimethyl-5-nitro-3-oxidobenzimidazol-1-ium 1-oxide |
Molecular Formula | C9H9N3O4 |
Purity | ≥95% |
InChI | InChI=1S/C9H9N3O4/c1-9(2)10(13)7-4-3-6(12(15)16)5-8(7)11(9)14/h3-5H,1-2H3 |
InChIKey | YLVSVJDCTDBERH-UHFFFAOYSA-N |
SMILES | CC1(N(C2=C([N+]1=O)C=CC(=C2)[N+](=O)[O-])[O-])C |
Reference | [1]. Zhang N, et al. Separase Inhibitor Sepin-1 Inhibits Foxm1 Expression and Breast Cancer Cell Growth. J Cancer Sci Ther. 2018;10(3):517. [2]. Zhang N, et al. Identification and Characterization of Separase Inhibitors (Sepins) for Cancer Therapy. J Biomol Screen. 2014 Jul;19(6):878-89. |